Aspiriant LLC’s iShares iBoxx $ High Yield Corporate Bond ETF HYG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $533K | Sell |
6,705
-13,667
| -67% | -$1.1M | 0.02% | 210 |
|
|
2025
Q4 | $1.64M | Buy |
20,372
+10,207
| +100% | +$823K | 0.05% | 128 |
|
|
2025
Q3 | $825K | Buy |
10,165
+83
| +0.8% | +$6.69K | 0.03% | 162 |
|
|
2025
Q2 | $813K | Buy |
10,082
+5,694
| +130% | +$449K | 0.03% | 161 |
|
|
2025
Q1 | $346K | Sell |
4,388
-330
| -7% | -$26.2K | 0.01% | 221 |
|
|
2024
Q4 | $371K | Buy |
4,718
+1,372
| +41% | +$109K | 0.01% | 219 |
|
|
2024
Q3 | $269K | Hold |
3,346
| – | – | 0.01% | 246 |
|
|
2024
Q2 | $258K | Buy |
+3,346
| New | +$257K | 0.01% | 249 |
|
|
2022
Q2 | – | Sell |
-8,141
| Closed | -$670K | – | 279 |
|
|
2022
Q1 | $670K | Sell |
8,141
-331
| -4% | -$27.7K | 0.04% | 155 |
|
|
2021
Q4 | $736K | Buy |
8,472
+563
| +7% | +$48.8K | 0.04% | 158 |
|
|
2021
Q3 | $692K | Buy |
7,909
+1
| +0% | +$88 | 0.04% | 139 |
|
|
2021
Q2 | $696K | Buy |
7,908
+136
| +2% | +$11.9K | 0.04% | 140 |
|
|
2021
Q1 | $678K | Sell |
7,772
-1,071
| -12% | -$93.2K | 0.04% | 128 |
|
|
2020
Q4 | $772K | Sell |
8,843
-1,910
| -18% | -$164K | 0.05% | 118 |
|
|
2020
Q3 | $902K | Buy |
10,753
+746
| +7% | +$62.8K | 0.07% | 104 |
|
|
2020
Q2 | $816K | Sell |
10,007
-1,566
| -14% | -$126K | 0.08% | 97 |
|
|
2020
Q1 | $891K | Sell |
11,573
-1,632
| -12% | -$138K | 0.09% | 84 |
|
|
2019
Q4 | $1.16M | Buy |
13,205
+443
| +3% | +$38.6K | 0.11% | 86 |
|
|
2019
Q3 | $1.11M | Buy |
12,762
+1,926
| +18% | +$167K | 0.1% | 97 |
|
|
2019
Q2 | $945K | Sell |
10,836
-1,729
| -14% | -$149K | 0.08% | 113 |
|
|
2019
Q1 | $1.09M | Sell |
12,565
-6,293
| -33% | -$534K | 0.09% | 104 |
|
|
2018
Q4 | $1.53M | Buy |
18,858
+10,313
| +121% | +$863K | 0.12% | 89 |
|
|
2018
Q3 | $739K | Buy |
8,545
+236
| +3% | +$20.3K | 0.06% | 124 |
|
|
2018
Q2 | $707K | Hold |
8,309
| – | – | 0.06% | 133 |
|
|
2018
Q1 | $712K | Buy |
+8,309
| New | +$718K | 0.06% | 126 |
|
|
2017
Q4 | – | Sell |
-8,267
| Closed | -$734K | – | 121 |
|
|
2017
Q3 | $734K | Buy |
8,267
+3,754
| +83% | +$331K | 0.06% | 123 |
|
|
2017
Q2 | $399K | Sell |
4,513
-170,070
| -97% | -$15M | 0.03% | 156 |
|
|
2017
Q1 | $2.45M | Sell |
174,583
-12,827
| -7% | -$1.12M | 0.21% | 76 |
|
|
2016
Q4 | $2.6M | Buy |
187,410
+181,893
| +3,297% | +$15.7M | 0.24% | 61 |
|
|
2016
Q3 | $481K | Sell |
5,517
-477
| -8% | -$41K | 0.05% | 140 |
|
|
2016
Q2 | $508K | Buy |
5,994
+2,024
| +51% | +$168K | 0.05% | 137 |
|
|
2016
Q1 | $324K | Sell |
3,970
-16,073
| -80% | -$1.28M | 0.03% | 150 |
|
|
2015
Q4 | $1.61M | Buy |
20,043
+8,272
| +70% | +$688K | 0.18% | 37 |
|
|
2015
Q3 | $980K | Buy |
+11,771
| New | +$1.02M | 0.08% | 56 |
|
|
2015
Q1 | – | Sell |
-2,958
| Closed | -$265K | – | 92 |
|
|
2014
Q4 | $265K | Buy |
+2,958
| New | +$269K | 0.04% | 77 |
|
Other funds holding HYG
CCMG
BCIM
JSTA
OTPPB
Aspiriant LLC's HYG Position: Q1 2026 in Review
Aspiriant LLC reduced its iShares iBoxx $ High Yield Corporate Bond ETF (HYG) stake by 67% in Q1 2026, selling an estimated $1.1M and leaving 6,705 shares worth $533K. The position accounts for 0.02% of the portfolio, ranked #210.
Aspiriant LLC first reported a position in HYG in Q4 2014 and has held it in 35 quarters since. The position peaked at $2.6M in Q4 2016. 978 funds tracked by Wall St. Rank hold HYG as of Q1 2026.
- Aspiriant LLC held 6,705 shares of iShares iBoxx $ High Yield Corporate Bond ETF worth $533K as of Q1 2026.
- Aspiriant LLC sold 13,667 iShares iBoxx $ High Yield Corporate Bond ETF shares in Q1 2026, an estimated $1.1M.
- iShares iBoxx $ High Yield Corporate Bond ETF made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #210 holding.
- Aspiriant LLC first reported a position in iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2014 and has held it in 35 quarters since.
- Aspiriant LLC's iShares iBoxx $ High Yield Corporate Bond ETF position peaked at $2.6M in Q4 2016.
- 978 funds tracked by Wall St. Rank held iShares iBoxx $ High Yield Corporate Bond ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.